247 related articles for article (PubMed ID: 22414003)
1. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
Fontaine MJ; Mills AM; Weiss S; Hong WJ; Viele M; Goodnough LT
Transfusion; 2012 Oct; 52(10):2081-5. PubMed ID: 22414003
[No Abstract] [Full Text] [Related]
2. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
[TBL] [Abstract][Full Text] [Related]
3. Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.
Worel N; Panzer S; Reesink HW; Linkesch W; Dickmeiss E; Fischer-Nielsen A; Hölig K; Stachel D; Zimmermann R; Holter W; Coluccia P; Brilhante D; Watz E; Sigle JP; Gratwohl A; Buser A; Arslan O; Regan F; Edwards M
Vox Sang; 2010 Apr; 98(3 Pt 2):455-67. PubMed ID: 20070647
[No Abstract] [Full Text] [Related]
4. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
Josephson CD; Mullis NC; Van Demark C; Hillyer CD
Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
[TBL] [Abstract][Full Text] [Related]
5. Hemolysis from platelet transfusion: call to action for an underreported reaction.
Quillen K
Transfusion; 2012 Oct; 52(10):2072-4. PubMed ID: 23110729
[No Abstract] [Full Text] [Related]
6. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
[TBL] [Abstract][Full Text] [Related]
7. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
8. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
9. Apheresis platelet transfusions: does ABO matter?
Herman JH; King KE
Transfusion; 2004 Jun; 44(6):802-4. PubMed ID: 15157242
[No Abstract] [Full Text] [Related]
10. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].
Peces R; Díaz Corte C; Navascués RA
Nefrologia; 2001; 21(4):395-401. PubMed ID: 11816517
[TBL] [Abstract][Full Text] [Related]
11. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
[TBL] [Abstract][Full Text] [Related]
12. [Immune hemolytic anemia caused by antibodies of the ABO system following ABO-incompatible kidney transplantation. Gm allotyping of the immune antibody].
Bein G; Poschmann A; Rob P
Beitr Infusionsther; 1988; 21():251-4. PubMed ID: 2462986
[No Abstract] [Full Text] [Related]
13. Erythrocyte survival tests in cases of anti-AnWj antibodies.
van Gaalen FA; Zanin DE; Brand A
Vox Sang; 2009 Oct; 97(3):275-6. PubMed ID: 19790299
[No Abstract] [Full Text] [Related]
14. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
15. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
Franchini M; Gandini G; Aprili G
Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
[TBL] [Abstract][Full Text] [Related]
16. Passenger lymphocyte syndrome after lung transplant.
Low M; Gregory G
Blood; 2012 Nov; 120(20):4122. PubMed ID: 23304710
[No Abstract] [Full Text] [Related]
17. Hemolysis in ABO-incompatible liver transplantation.
Angstadt J; Jarrell B; Maddrey W; Munoz S; Yang SL; Moritz M; Carabasi A
Transplant Proc; 1987 Dec; 19(6):4595-7. PubMed ID: 3321627
[No Abstract] [Full Text] [Related]
18. Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation.
Bonstein L; Stemer G; Dann EJ; Zuckerman T; Fineman R; Haddad N
Transfusion; 2013 May; 53(5):1019-23. PubMed ID: 22897696
[TBL] [Abstract][Full Text] [Related]
19. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
[TBL] [Abstract][Full Text] [Related]
20. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
Sniecinski IJ; Petz LD; Oien L; Blume KG
Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
